The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma

Genes Chromosomes and Cancer

Volumn 29, Issue 1, 2000, Pages 48-57

  Balleine, Rosemary L ^a   Fejzo, Marlena Schoenberg ^b   Sathasivam, Pavani ^c   Basset, Paul ^d   Clarke, Christine L ^a   Byrne, Jennifer A ^c,e  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CHROMOSOME 8Q; CLINICAL ARTICLE; GENE DOSAGE; GENE EXPRESSION; GENE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOGENE; PRIORITY JOURNAL; SOUTHERN BLOTTING;

ANEUPLOIDY; BINDING, COMPETITIVE; BLOTTING, SOUTHERN; BREAST NEOPLASMS; CELL LINE; CHROMOSOMES, HUMAN, PAIR 8; CONTIG MAPPING; GENE DOSAGE; GENE EXPRESSION; HUMANS; IMMUNE SERA; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0033855392     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2264(2000)9999:9999<::AID-GCC1005>3.0.CO;2-O     Document Type: Article

References (46)

1. Afify A, Bland KI, Mark HFL. 1996. Fluorescent in situ hybridization assessment of chromosome 8 copy number in breast cancer. Breast Cancer Res Treat 38:201-208.
2. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan X-Y, Sauter G, Kallioniemi O-P, Trent JM, Meltzer PS. 1997. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965-968.
3. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, editors. 1997. Current Protocols in Molecular Biology, vol 1. New York: John Wiley & Sons.
4. Balsara BR, Sonoda G, du Manoir S, Siegfried JM, Gabrielson E, Testa JR. 1997. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res 57:2116-2120.
5. i. Am J Physiol 257: G99-G110.
6. Byrne JA, Tomasetto C, Garnier J-M, Rouyer N, Mattei M-G, Bellocq J-P, Rio M-C, Basset P. 1995. A screening method to identify genes commonly overexpressed in carcinomas and the identification of a novel complementary DNA sequence. Cancer Res 55:2896-2903.
7. Byrne JA, Mattei M-G, Basset P. 1996. Definition of the D52 gene/protein family through cloning of D52 homologues in human (hD53) and mouse (mD52). Genomics 35:523-532.
8. Byrne JA, Nourse CR, Basset P, Gunning P. 1998. Identification of homo-and heteromeric interactions between members of the breast carcinoma-associated D52 protein family using the yeast two-hybrid system. Oncogene 16:873-882.
9. Chen S-L, Maroulakou IG, Green JE, Romano-Spica V, Modi W, Lautenberger J, Bhat NK. 1996. Isolation and characterization of a novel gene expressed in multiple cancers. Oncogene 12:741-751.
10. Chen S-L, Zhang X-K, Halverson DO, Byeon MK, Schweinfest CW, Ferris DK, Bhat NK. 1997. Characterization of human N8 protein. Oncogene 15:2577-2588.
11. Cher ML, MacGrogan D, Bookstein R, Brown JA, Jenkins RB, Jensen RH. 1994. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosomes Cancer 11:153-162.
12. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH. 1996. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization. Cancer Res 56: 3091-3102.
13. Collins C, Rommens JM, Kowbel D, Godfrey T, Tanner M, Hwang S, Polikoff D, Nonet G, Cochran J, Myambo K, Jay KE, Froula J, Cloutier T, Kuo W-L, Yaswen P, Dairkee S, Giovanola J, Hutchinson GB, Isola J, Kallioniemi O-P, Palazzolo M, Martin C, Ericsson C, Pinkel D, Albertson D, Li W-B, Gray JW. 1998. Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci USA 95:8703-8708.
14. Courjal F, Cuny M, Simony-Lafontaine J, Louason G, Speiser P, Zeillinger R, Rodriguez C, Theillet C. 1997. Mapping of DNA amplifications at 15 chromosomal locations in 1875 breast tumors: definition of phenotypic groups. Cancer Res 57:4360-4367.
15. Courjal F, Theillet G. 1997. Comparative genomic hybridization of breast tumors with predetermined profiles of DNA amplification. Cancer Res 57:4368-4377.
16. Forozan F, Karhu R, Kononen J, Kallioniemi A, Kallioniemi O-P. 1997. Genome screening by comparative genomic hybridization. Trends Genet 13:405-409.
17. Fujiwara Y, Monden M, Mori T, Nakamura Y, Emi M. 1993. Frequent multiplication of the long arm of chromosome 8 in hepatocellular carcinoma. Cancer Res 53:857-860.
18. Isola JJ, Kallioniemi OP, Chu LW, Fuqua SAW, Hilsenbeck SG, Osborne CK, Waldman FM. 1995. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 147:905-911.
19. Jenkins RB, Qian J, Lieber MM, Boswick DG. 1997. Detection of c-myc amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res 57:524-531.
20. Kallioniemi A, Kallioniemi O-P, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM. 1994. Detection and mapping of amplified DNA sequences in breast cancer by compatative genomic hybridization. Proc Natl Acad Sci USA 91-2156-2160.
21. Kallioniemi A, Kallioniemi OP, Citro G, Sauter G, DeVries S, Kerschmann R, Caroll P, Waldman F. 1995. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer 12: 213-219.
22. Knuutila S, Björkqvist A-M, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, Wasenius V-M, Vidgren V, Zhu Y. 1998. DNA copy number amplifications in human neoplasms. Am J Pathol 152: 1107-1123.
23. Maddox J. 1995. Directory to the human genome. Nature 376:459-460.
24. Muleris M, Almeida A, Gerbault-Seureau M, Malfoy B, Dutrillaux B. 1994. Detection of DNA amplification in 17 primary breast carcinomas with homogenously staining regions by a modified comparative genomic hybridization technique. Genes Chromosomes Cancer 10:160-170.
25. Nishizaki T, Chew K, Chu L, Isola J, Kallioniemi A, Weidner N, Waldman FM. 1997a. Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer (Pred Oncol) 74:513-517.
26. Nishizaki T, DeVries S, Chew K, Goodson WH III, Ljung B-M, Thor A, Waldman FM. 1997b. Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer 19:267-272.
27. Nourse CR, Mattei M-G, Gunning P, Byrne JA. 1998. Cloning of a third member of the D52 gene family indicates alternative coding sequence usage in D52-like transcripts. Biochim Biophys Acta 1443:155-168.
28. Nupponen NN, Porkka K, Kakkola L, Tanner M, Persson K, Borg A, Isola J, Visakorpi T. 1999. Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. Am J Pathol 154:1777-1783.
29. Parente JA Jr, Goldenring JA, Petropoulos AC, Hellman U, Chew CS. 1996. Purification, cloning and expression of a novel, endogenous, calcium-sensitive, 28-kDa phosphoprotein. J Biol Chem 271:20096-20101.
30. Petersen I, Bujard M, Petersen S, Wolf G, Goeze A, Schwendel A, Langreck H, Gellert K, Reichel M, Just K, du Manoir S, Cremer T, Dietel M, Ried T. 1997. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 57:2331-2335.
31. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo W-L, Chen C, Zhai Y, Dairkee SH, Ljung B, Gray JW, Albertson DG. 1998. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20:207-211.
32. Proux V, Provot S, Felder-Schmittbuhl M-P, Laugier D, Calothy G, Marx M. 1996. Characterization of a leucine zipper-containing protein identified by retroviral insertion in avian neuroretina cells. J Biol Chem 271:30790-30797.
33. Richter J, Görög J-P, Sartorius G, Egenter C, Gasser TC, Moch H, Mihatsch MJ, Sauter G. 1997. Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 57:2860-2864.
34. Ried T, Just KE, Holtgreve-Grez H, du Manoir S, Speicher MR, Schroeck E, Latham C, Biegen H, Zetterberg A, Cremer T, Auer G. 1995. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res 55:5415-5423.
35. Schoenberg Fejzo M, Godfrey T, Chen C, Waldman F, Gray JW. 1998. Molecular cytogenetic analysis of consistent abnormalities at 8q12-q22 in breast cancer. Genes Chromosomes Cancer 22: 105-113.
36. Schwab M. 1998. Amplification of oncogenes in human cancer cells. BioEssays 20:473-479.
37. Schwab M, Amler LC. 1990. Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer. Genes Chromosomes Cancer 1:181-193.
38. Solinas-Toldo S, Wallrapp C, Mueller-Pillasch F, Bentz M, Gress T, Lichter P. 1996. Mapping of chromosomal imbalances in pancreatic catcinoma by comparative genomic hybridization. Cancer Res 56:3803-3807.
39. Sonoda G, Palazzo J, du Manoir S, Godwin AK, Feder M, Yakushiji M, Testa JR. 1997. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24 and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer 20:320-328.
40. Tarkkanen M, Karhu R, Kallioniemi A, Elomaa I, Kivioja AH, Nevalainen J, Böhling T, Karaharju E, Hyytinen E, Knuutila S, Kallioniemi O-P. 1995. Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res 55:1334-1338.
41. Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J, Kallioniemi O-P. 1998. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer 21:177-184.
42. Van Den Berg C, Guan X-Y, Von Hoff D, Jenkins R, Bittner M, Griffin C, Kallioniemi O, Visakorpi T, McGill J, Herath J, Epstein J, Sarosdy M, Meltzer P, Trent J. 1995. DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications. Clin Cancer Res 1:11-18.
43. Visakorpi T, Kallioniemi AH, Syvänen A-C, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi O-P. 1995. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347.
44. Visscher DW, Wallis T, Awussah S, Mohamed A, Crissman JD. 1997. Evaluation of MYC and chromosome 8 copy number in breast carcinoma by interphase cytogenetics. Genes Chromosomes Cancer 18:1-7.
45. Wallrapp C, Mueller-Pillasch F, Solinas-Toldo S, Lichter P, Friess H, Buechler M, Fink T, Adler G, Gress TM. 1997. Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene. Cancer Res 57:3135-3139.
46. Zhou H, Kuang J, Zhong L, Kuo W, Gray JW, Sahin A, Brinkley BR, Sen S. 1998. Tumor amplified kinase STK15/BTAK induces centrosome amplification, aneupoidy and transformation. Nat Genet 20:189-193.